- Report
- August 2025
- 190 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- October 2024
- 195 Pages
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- August 2025
- 189 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- August 2025
- 193 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- August 2025
- 188 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- August 2025
- 188 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- December 2024
- 150 Pages
Global
From €5254EUR$5,950USD£4,554GBP
- Report
- August 2025
- 180 Pages
Global
From €3130EUR$3,545USD£2,713GBP
€3478EUR$3,939USD£3,015GBP
- Report
- April 2025
- 150 Pages
Global
From €3399EUR$3,850USD£2,947GBP
€4282EUR$4,850USD£3,712GBP
- Report
- February 2025
- 150 Pages
Global
From €3399EUR$3,850USD£2,947GBP
€4282EUR$4,850USD£3,712GBP
- Report
- February 2025
- 150 Pages
Global
From €3399EUR$3,850USD£2,947GBP
€4282EUR$4,850USD£3,712GBP
- Report
- February 2025
- 150 Pages
Global
From €3399EUR$3,850USD£2,947GBP
€4282EUR$4,850USD£3,712GBP
- Report
- August 2025
- 250 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- March 2025
- 294 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- January 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,436GBP
- Report
- August 2025
- 194 Pages
Global
From €5165EUR$5,850USD£4,477GBP

The Oral Vaccine market is a subset of the larger Vaccines market, which is focused on the development and distribution of vaccines to prevent and treat infectious diseases. Oral Vaccines are administered orally, rather than through injection, and are typically used to protect against gastrointestinal infections. These vaccines are often used in developing countries, where access to injection-based vaccines may be limited. Oral Vaccines are also used in certain circumstances where injection-based vaccines may not be suitable, such as in the elderly or immunocompromised individuals.
Oral Vaccines are typically composed of weakened or killed pathogens, which stimulate the body’s immune system to produce antibodies against the disease. These vaccines are typically administered in multiple doses, and may require booster shots to maintain immunity.
Some companies in the Oral Vaccine market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more